SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001354488-11-003018
Filing Date
2011-08-22
Accepted
2011-08-22 15:42:22
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 slxcf_10qa.htm 10-Q/A 42142
  Complete submission text file 0001354488-11-003018.txt   1233522

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT slxcf-20110630.xml EX-101.INS 184006
3 XBRL TAXONOMY EXTENSION SCHEMA slxcf-20110630.xsd EX-101.SCH 11753
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxcf-20110630_cal.xml EX-101.CAL 31543
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxcf-20110630_def.xml EX-101.DEF 8077
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxcf-20110630_lab.xml EX-101.LAB 73987
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxcf-20110630_pre.xml EX-101.PRE 58697
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-31198 | Film No.: 111049865
SIC: 2834 Pharmaceutical Preparations